Contrast-Enhanced US Using Perfluorobutane for Diagnosing Small HCC in High-Risk Patients: Comparison with MRI LI-RADS Version 2018

Radiology 2026

View at publisher
Authors: Yu Li, Shilin Lu, Siyue Mao, Qing Li, Xuebin Zou, Sheng Li, Xiaoxian Li, D B Lu, Min Xu, H Xu, Tianan Jiang, Andrej Lyshchik
+2 more Lingling Li, J Zhou
DOI: 10.1148/radiol.252271
Cited by: 2
References: 28

Abstract

= .39], respectively) in patients without cirrhosis versus in patients with cirrhosis. Conclusion In patients at high risk for HCC, PFB CEUS incorporating Kupffer-phase findings was effective for diagnosing small HCC, with diagnostic performance similar to MRI. © RSNA, 2026

Fields of Study & Subjects

Hepatocellular Carcinoma Treatment and Prognosis MRI in cancer diagnosis Cancer Hypoxia and Metabolism

Publication details

Journal / source
Radiology
Publisher
Radiological Society of North America (RSNA)
Volume
318
Issue
3
Pages
e252271–e252271
Publication date
1 March 2026
Language
EN